ArchivesTag : Actos
FDA Warns of Bladder Cancer Risk from Diabetes Drug Actos
Diabetics taking Actos (pioglitazone) for more than one year may have a significantly increased risk of bladder cancer, according to an FDA interim review of an ongoing epidemiological study. The warning comes just days after two European countries, Germany and France, banned use of the drug. Five-year data show that although there is no overall increased [...]
Full Story